Cargando…

Biothreat Agents and Emerging Infectious Disease in the Emergency Department

The challenges faced by the emergency physician with recognizing and treating category A biothreat agents and emerging infectious disease are summarized and reviewed.

Detalles Bibliográficos
Autor principal:	Adalja, Amesh A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125859/ https://www.ncbi.nlm.nih.gov/pubmed/30297007 http://dx.doi.org/10.1016/j.emc.2018.06.011

Ejemplares similares

Pathogenic Bacilli as an Emerging Biothreat?
por: Mondange, Lou, et al.
Publicado: (2022)

At-home infectious disease testing: An idea whose time has come
por: Adalja, Amesh A.
Publicado: (2022)

Viral Biothreat Agents
por: Anderson, Kevin
Publicado: (2009)

Rational monoclonal antibody development to emerging pathogens, biothreat agents and agents of foreign animal disease: The antigen scale
por: Berry, Jody D.
Publicado: (2005)

Advances in Molecular Diagnostic Approaches for Biothreat Agents
por: Rastogi, Meghana, et al.
Publicado: (2019)

Advance detection technologies for select biothreat agents
por: Parida, M.M., et al.
Publicado: (2020)

Advances in Development of Countermeasures for Potential Biothreat Agents
por: Pittman, Phillip R., et al.
Publicado: (2012)

The words that shaped COVID-19
por: Adalja, Amesh
Publicado: (2021)

Comparative Antimicrobial Activity of Granulysin against Bacterial Biothreat Agents
por: Endsley, Janice J, et al.
Publicado: (2009)

Deadliest Enemy: Our War against Killer Germs
por: Adalja, Amesh A.
Publicado: (2018)

Anthrax: has the clinical milieu changed since 2001?
por: Adalja, Amesh A.
Publicado: (2012)

Agents of Emerging Infectious Diseases
por: Olano, Juan P., et al.
Publicado: (2009)

Protein Microarrays for the Detection of Biothreats
por: Herr, Amy E.
Publicado: (2009)

VOC fingerprints: metabolomic signatures of biothreat agents with and without antibiotic resistance
por: Dailey, Allyson, et al.
Publicado: (2020)

Targeted amplification for enhanced detection of biothreat agents by next-generation sequencing
por: Gardner, Shea N., et al.
Publicado: (2015)

Patents as a Driver of the Unprecedented Biomedical Response to COVID-19
por: Mossoff, Adam, et al.
Publicado: (2022)

Strengthening the US Medical Countermeasure Enterprise for Biological Threats
por: Ravi, Sanjana, et al.
Publicado: (2017)

Perspective on Improving Environmental Monitoring of Biothreats
por: Dunbar, John, et al.
Publicado: (2018)

Testing and Validation of High Density Resequencing Microarray for Broad Range Biothreat Agents Detection
por: Leski, Tomasz A., et al.
Publicado: (2009)

Enabling emergency mass vaccination: Innovations in manufacturing and administration during a pandemic
por: Hosangadi, Divya, et al.
Publicado: (2020)

Clostridium difficile: moving beyond antimicrobial therapy
por: Adalja, Amesh A, et al.
Publicado: (2010)

Original Antigenic Sin and Pandemic (H1N1) 2009
por: Adalja, Amesh A., et al.
Publicado: (2010)

Innovative approaches to COVID-19 medical countermeasure development
por: Harris, Gavin H, et al.
Publicado: (2023)

Primordial and Primary Levels of Biothreat and Bioterrorism Prevention
por: Radosavljevic, Vladan
Publicado: (2018)

Rapid diagnostic tests for infectious diseases in the emergency department
por: Bouzid, D., et al.
Publicado: (2021)

Management of Travel-Related Infectious Diseases in the Emergency Department
por: Throckmorton, Laura, et al.
Publicado: (2020)

A Joint Exercise against Intentional Biothreats
por: Cho, Hae-Wol, et al.
Publicado: (2018)

Response to the COVID-19 Outbreak in The Emergency Department Designed for Emerging Infectious Diseases in Korea
por: Cho, Soo Im, et al.
Publicado: (2021)

Emergency nurses’ perceptions regarding the risks appraisal of the threat of the emerging infectious disease situation in emergency departments
por: Lam, Stanley Kam Ki, et al.
Publicado: (2020)

Genetically Modified (GM) Mosquito Use to Reduce Mosquito-Transmitted Disease in the US: A Community Opinion Survey
por: Adalja, Amesh, et al.
Publicado: (2016)

616. Predicting Misdiagnoses of Infectious Disease in Emergency Department Visits
por: Chapman, Alec B, et al.
Publicado: (2021)

Biothreat & One Health: Current scenario & way forward
por: Kotwal, Atul, et al.
Publicado: (2021)

Efficacy of Delafloxacin against the Biothreat Pathogen Burkholderia pseudomallei
por: McCurdy, Sandra, et al.
Publicado: (2021)

A Biomarker-Based Approach to Infectious Disease in the Pediatric Emergency Department
por: Aranke, Mayank, et al.
Publicado: (2013)

The Management of Infectious Pulmonary Processes in the Emergency Department: Pneumonia
por: Dillon, Kasey, et al.
Publicado: (2023)

Appendix P: Guidance for Soil Collection, Characterization, and Application for Biothreat Agent Detection Method and Site Evaluations
por: Brunelle, Sharon
Publicado: (2020)

Aminomethyl spectinomycins: a novel antibacterial chemotype for biothreat pathogens
por: Scarff, Jennifer M., et al.
Publicado: (2019)

Emerging and Re-emerging Infectious Diseases
por: Georgiev, Vassil St.
Publicado: (2009)

Emerging and Re-emerging Infectious Diseases
por: Löscher, Thomas, et al.
Publicado: (2009)

Lessons Learned during Dengue Outbreaks in the United States, 2001–2011
por: Adalja, Amesh A., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_hho9qpkt7l3k5cg0g4dguephv5